BNP Paribas Financial Markets’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
|
|||||
|
2025
Q1 | $108K | Sell |
|
|||||
|
2024
Q4 | $889K | Sell |
|
|||||
|
2024
Q3 | $1.65M | Sell |
|
|||||
|
2024
Q2 | $1.97M | Buy |
|
|||||
|
2024
Q1 | $2.68M | Buy |
|
|||||
|
2023
Q4 | $1.53M | Buy |
|
|||||
|
2023
Q3 | $2.23M | Buy |
|
|||||
|
2023
Q2 | $825K | Buy |
|
|||||
|
2023
Q1 | $1.44M | Sell |
|
|||||
|
2022
Q4 | $1.44M | Sell |
|
|||||
|
2022
Q3 | $4.16M | Buy |
|
|||||
|
2022
Q2 | $2.64M | Buy |
|
|||||
|
2022
Q1 | $63K | Sell |
|
|||||
|
2021
Q4 | $92.7K | Sell |
|
|||||
|
2021
Q3 | $2.73M | Buy |
|
|||||
|
2021
Q2 | $4.05M | Buy |
|
|||||
|
2021
Q1 | $92.8K | Sell |
|
|||||
|
2020
Q4 | $1.47M | Buy |
|
|||||
|
2020
Q3 | $237K | Buy |
|
|||||
|
2020
Q2 | $201K | Sell |
|
|||||
|
2020
Q1 | $714K | Buy |
|
|||||
|
2019
Q4 | $133K | Sell |
|
|||||
|
2019
Q3 | $78.6K | Buy |
|
|||||
|
2019
Q2 | $32.5K | Sell |
|
|||||
|
2019
Q1 | $59.4K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $27.2K | Hold |
|
|||||
|
2018
Q2 | $27.1K | Sell |
|
|||||
|
2018
Q1 | $106K | Buy |
|
|||||
|
2017
Q4 | $68.4K | Buy |
|
|||||
|
2017
Q3 | $47.8K | Sell |
|
|||||
|
2017
Q2 | $40.2K | Buy |
|
|||||
|
2017
Q1 | $12.8K | Sell |
|
|||||
|
2016
Q4 | $12.6K | Sell |
|
|||||
|
2016
Q3 | $17.1K | Buy |
|
|||||
|
2016
Q2 | $6.24K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $60.7K | Sell |
|
|||||
|
2015
Q3 | $54.1K | Buy |
|
|||||
|
2015
Q2 | $52.3K | Buy |
|
|||||
|
2015
Q1 | $9.03K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $30.6K | Buy |
|
|||||
|
2014
Q2 | $1.58K | Hold |
|
|||||
|
2014
Q1 | $644 | Sell |
|
|||||
|
2013
Q4 | $2.2K | Buy |
|